ÂÜÀòÂÒÂ×

Dragan Nebrigic

Chief Operating & Chief Technology Officer at Vigilant Biosciences

Dragan joined Vigilant Biosciences in January 2020 as COO to lead product development and global operations including offshore and domestic manufacturing. Dragan brings 30 years of medical device experience working in various management roles. He holds over 60 US and International Patents in the area of medical devices, consumer electronics, and medical sensor technologies. Previously, Dragan served as Chief Operating Officer/Chief Technical Officer of Perseon Corporation focusing on interventional radiology cancer treatments. In 2012, he was appointed Chief Technical Officer by Inova Labs where he successfully developed and released to the market ACTIVOX, a portfolio of portable oxygen products. The company was acquired by ResMed in 2016 and he was appointed Vice President of R&D, Oxygen Products. Prior to working at Inova Labs, Dragan served as Vice President of R&D at Thermage, as well as, Vice President of Research and Development/Chief Scientist with Solta Medical. He also held the position of Senior Director of Global Advanced Technologies and IP with Maxwell Technologies. Dragan served as the Executive Director of Engineering and Advanced Technologies with the American Technology Corporation and Molecular Reflections Corporation in biopharma advanced sensors. During his tenure with Procter and Gamble from 1996 until 2000, Dragan spearheaded efforts related to novel new consumer biosensors and portable medical device applications. Dr. Nebrigic held an adjunct Professor position in Electrical Engineering with the University of Cincinnati.